|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 21, 2017 ) According to Publisher, the Global Hemostasis Products market is accounted for $5.78 billion in 2016 and is expected to reach $7.98 billion by 2022 growing at a CAGR of 5.5% during the forecast period 2016 to 2022. This process helps to cease the bleeding and keeps blood within the blood vessel. This procedure is useful in heavy bleeding surgeries and severe wound conditions. Increased rate of introduction in bio-degradable and cost effective market is driving the market. Whereas, high cost structures of Hemostasis product varieties are hampering the market growth.
For more information http://www.reportsweb.com/hemostasis-products-global-market-outlook-2016-2022
Advanced Hemostasis & Sealants segment is estimated to have dominant usage in the product type segment because of its cost effectiveness and bio degradable nature. North American market is estimated to have dominant share in market on account of high healthcare expenditure and technological advancements for providing innovative product. Asia Pacific market is expected to have highest market growth due to medical tourism and surgical procedures.
Some of the key players of the Hemostasis Products market include Abbott Laboratories, Baxter International, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, C. R. Bard, Inc., Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols, S.A., HemCon Medical Technologies, Inc., Integra Life Sciences Corporation, Johnson & Johnson, Medtronic plc, Pfizer, Inc., Siemens AG, Thermo Fisher Scientific, Inc. and Trinity Biotech plc.
End-Users Covered:
-Clinics
-Hospitals
Applications covered:
-Hemophilia
-Myocardial Infarction
-Stroke
-Surgery
-Thrombosis
-Trauma
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001792560/sample
Product Types covered:
-Infusible Hemostasis -Fresh Frozen Plasma-FVIII Derived from Blood-Platelet Concentrates from Donor Blood-Prothrombin Complex
-Topical Hemostasis -Collagen-Gelatin-Oxidized Regenerated Cellulose-Polysaccharide
-Advanced Hemostasis & Sealants -Fibrin-Flowable-Synthetic Sealants-Thrombin
Regions Covered:
-North America-US-Canada-Mexico
-Europe-Germany-France-Italy-UK -Spain -Rest of Europe
-Asia Pacific-Japan-China-India-Australia-New Zealand-Rest of APAC
-Rest of the World-Middle East-Brazil-Argentina-South Africa-Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001792560/buying
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Hemostasis Products Market, By End-User
6 Global Hemostasis Products Market, By Application
7 Global Hemostasis Products Market, By Product Type
8 Global Hemostasis Products Market, By Geography
9 Key Developments
10 Key Developments
10 Company Profiling
10.1 Abbott Laboratories
10.2 Baxter International, Inc.
10.3 Beckman Coulter, Inc.
10.4 Becton, Dickinson and Company
10.5 C. R. Bard, Inc.
10.6 Chrono-Log Corporation
10.7 CSL Behring LLC
10.8 F. Hoffmann-La Roche Ltd.
10.9 Grifols, S.A.
10.10 HemCon Medical Technologies, Inc.
10.11 Integra LifeSciences Corporation
10.12 Johnson & Johnson
10.13 Medtronic plc
10.14 Pfizer, Inc.
10.15 Siemens AG
10.16 Thermo Fisher Scientific, Inc.
10.17 Trinity Biotech plc.
Purchase Report at http://www.reportsweb.com/buy&RW0001792560/buy/4150
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
